Position in PFE
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,627,907
+$1,473,261 QoQ
Shares Held
129,199
+49.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $104,513,791 across 18 Drug Manufacturers - General names. PFE ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,405 | $27,965,606 | |
| 2 | ABBV |
AbbVie Inc.
|
103,875 | $22,591,773 | |
| 3 | JNJ |
Johnson & Johnson
|
80,406 | $19,654,442 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
75,984 | $10,589,890 | |
| 5 | MRK |
Merck & Co., Inc.
|
56,169 | $6,756,569 | |
| 6 | PFE |
Pfizer Inc
This page
|
129,199 | $3,627,907 | |
| 7 | AMGN |
Amgen Inc
|
10,183 | $3,582,888 | |
| 8 | NVS |
Novartis AG
|
16,366 | $2,499,906 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,627,907 | 129,199 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,154,646 | 86,532 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,380,112 | 93,411 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,238,442 | 92,345 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $2,549,026 | 100,593 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $2,521,570 | 95,046 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,600,801 | 124,423 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,026,876 | 108,180 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,519,977 | 90,810 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,845,640 | 64,107 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,582,384 | 77,853 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $3,367,554 | 91,809 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $3,525,976 | 86,421 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $4,108,986 | 80,191 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $3,101,927 | 70,885 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,910,019 | 74,576 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,759,226 | 72,614 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $4,882,785 | 82,689 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $3,443,079 | 80,053 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $2,919,378 | 74,550 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,405,998 | 66,409 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,395,521 | 65,078 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,476,770 | 67,487 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $2,150,812 | 65,774 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $1,831,623 | 56,116 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||